Intestinal CD11b+ B Cells Ameliorate Colitis by Secreting Immunoglobulin A

Ying Fu, Zhiming Wang, Baichao Yu, Yuli Lin, Enyu Huang, Ronghua Liu, Chujun Zhao, Mingfang Lu, Wei Xü, Hongchun Liu,

Frontiers in Immunology · 2021 · 23 citations · 36 references

DOIFull text

Open access

Abstract

The intestinal mucosal immune environment requires multiple immune cells to maintain homeostasis. Although intestinal B cells are among the most important immune cells, little is known about the mechanism that they employ to regulate immune homeostasis. In this study, we found that CD11b<sup>+</sup> B cells significantly accumulated in the gut lamina propria and Peyer's patches in dextran sulfate sodium-induced colitis mouse models and patients with ulcerative colitis. Adoptive transfer of CD11b<sup>+</sup> B cells, but not CD11b<sup>-/-</sup> B cells, effectively ameliorated colitis and exhibited therapeutic effects. Furthermore, CD11b<sup>+</sup> B cells were found to produce higher levels of IgA than CD11b<sup>-</sup> B cells. CD11b deficiency in B cells dampened IgA production, resulting in the loss of their ability to ameliorate colitis. Mechanistically, CD11b<sup>+</sup> B cells expressed abundant TGF-β and TGF-β receptor II, as well as highly activate phosphorylated Smad2/3 signaling pathway, consequently promoting the class switch to IgA. Collectively, our findings demonstrate that CD11b<sup>+</sup> B cells are essential intestinal suppressive immune cells and the primary source of intestinal IgA, which plays an indispensable role in maintaining intestinal homeostasis.

References

36